je.st
news
Tag: clinical
FDA Clears AQUIOS CL Flow Cytometer for Routine Immunophenotyping Applications in US Clinical Labs
2015-05-12 12:31:16| Industrial Newsroom - All News for Today
Fully Automated Instrument Speeds Workflow for Fast, Efficient Results INDIANAPOLIS Beckman Coulters new, automated AQUIOS CL Flow Cytometer has received clearance from the U.S. Food and Drug Administration (FDA) for use in the clinical laboratory. The small footprint, high precision LOAD GO instrument has...
Tags: us
applications
flow
clinical
Gaumard to Feature Victoria Birthing Simulator at ACOG Annual Clinical and Scientific Meeting
2015-05-04 12:31:11| Industrial Newsroom - All News for Today
Company Also to Exhibit its Family of Maternal and Neonatal Care Simulators as Part of the Industry's Most Comprehensive Lineup MIAMI Gaumard Scientific Company (www.gaumard.com) today announced it will feature the Victoria birthing simulator at the American College of Obstetricians and Gynecologists 2015...
Tags: meeting
feature
annual
scientific
Cambridge Semantics And Informa Named Bio-IT Award Finalist For Smart Data Lake Solution For Clinical Trial And Competitive Intelligence
2015-04-29 05:05:34| drugdiscoveryonline Home Page
Cambridge Semantics, the leading provider of smart data solutions driven by Semantic Web technology, and Informa, the leading international provider of specialist information and services for the academic and scientific, professional and commercial business communities, today announced that its joint solution ‘Smart Data Lake for Clinical Trial and Competitive Intelligence’ was named a finalist for the 2015 Bio-IT ‘Best of Show’ Award
Tags: data
solution
trial
lake
PPD Honored For Patient-Centric Communications On Clinical Research
2015-04-29 04:09:43| drugdiscoveryonline Home Page
Pharmaceutical Product Development, LLC (PPD) recently announced it has won recognition for a patient-centered communications campaign demonstrating the company’s commitment to helping biopharmaceutical clients deliver life-changing medical treatments
Tags: research
communications
clinical
honored
Merck Announces Publication of Pivotal Data from Phase 3 Clinical Studies of ZERBAXA (Ceftolozane/Tazobactam) in The Lancet and Clinical Infectious Diseases
2015-04-28 00:30:00| Merck.com - Corporate News
Dateline City: KENILWORTH, N.J. KENILWORTH, N.J.--(BUSINESS WIRE)--Merck (NYSE:MRK), known as MSD outside the United States and Canada, today announced that The Lancet and Clinical Infectious Diseases have published online the results from the pivotal Phase 3 clinical studies of ZERBAXA (ceftolozane/tazobactam) for Injection (1 g/0.5 g) in complicated urinary tract infections (cUTI) and complicated intra-abdominal infections (cIAI), respectively. The results will also appear in forthcoming print issues of the journals. Language: English Contact: MerckMedia Contacts:Pam Eisele, 267-305-3558Robert Consalvo, 908-295-0928orInvestor Contacts:Joseph Romanelli, 908-740-1986Justin Holko, 908-740-1879 Ticker Slug: Ticker: MRK Exchange: NYSE read more
Tags: the
data
publication
studies
Sites : [6] [7] [8] [9] [10] [11] [12] [13] [14] [15] [16] [17] [18] [19] [20] [21] [22] [23] [24] [25] next »